| Literature DB >> 21658215 |
Dan Robotham1, Michael King, Anton Canagasabey, Sophie Inchley-Mort, Angela Hassiotis.
Abstract
BACKGROUND: Randomised controlled trials (RCTs) are the gold standard of evidence-based practice in medicine but they have had limited influence in the field of intellectual disabilities. Previous literature suggests that participants and professionals have limited tolerance for this type of research methodology. However, it is not known how well service users, carers and other health professionals understand and accept the need for RCTs, and why it is important for individuals with intellectual disabilities to be included in this kind of research.Entities:
Mesh:
Year: 2011 PMID: 21658215 PMCID: PMC3135548 DOI: 10.1186/1745-6215-12-144
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Socio-demographic characteristics of participants
| Professional | Carer | Service User | Total | |
|---|---|---|---|---|
| Male | 9 (33.3%) | 1 (5.6%) | 3 (50.0%) | 13 (25.5%) |
| Female | 18 (66.7%) | 17 (94.4%) | 3 (50.0%) | 38 (74.5%) |
| 22-25 | 0 (0.0%) | 1 (5.6%) | 0 (0.0%) | 1 (2.0%) |
| 26-30 | 3 (11.1%) | 1 (5.6%) | 3 (50.0%) | 7 (13.7%) |
| 31-40 | 5 (18.5%) | 1 (5.6%) | 3 (50.0%) | 9 (17.6%) |
| 41-50 | 7 (25.9%) | 2 (11.1%) | 0 (0.0%) | 9 (17.6%) |
| 51-60 | 10 (37.0%) | 11 (61.1%) | 0 (0.0%) | 21 (41.2%) |
| 61+ | 2 (7.4%) | 2 (11.1%) | 0 (0.0%) | 4 (7.8%) |
| Mean = 17.6 yrs | Mean = 13.4 yrs | |||
| 1-5 | 4 (14.8%) | 1 (5.6%) | - | - |
| 6-10 | 5 (18.5%) | 3 (16.7%) | - | - |
| 11-20 | 6 (22.2%) | 5 (27.8%) | - | - |
| 21-30 | 7 (25.9%) | 2 (11.1%) | - | - |
| 31+ | 4 (14.8%) | 0 (0.00%) | - | - |
| - | - | |||
| Health care | n=20 | - | - | - |
| Nursing role | 15 | - | - | - |
| Psychiatrist | 2 | - | - | - |
| Psychologist | 1 | - | - | - |
| Speech therapist | 1 | - | - | - |
| Occupational therapist | 1 | - | - | - |
| Social Care | n = 7 | - | - | - |
Emerging themes and frequency per participant group
| Theme | Service | Carers | Professionals | Total |
|---|---|---|---|---|
| Safeguarding | 1 | 1 | 17 | 19 |
| Motivation | 3 | 14 | 3 | 20 |
| Disadvantage/labelling | 3 | 6 | 12 | 21 |
| Fairness | 5 | 16 | 13 | 34 |
| Access | 4 | 9 | 24 | 37 |
| Funding/resources | 2 | 13 | 23 | 38 |
| Seeking help and support | 4 | 16 | 19 | 39 |
| Research outcomes | 3 | 15 | 23 | 41 |
| Research within services | 1 | 15 | 27 | 43 |
| Communication/understanding | 5 | 13 | 25 | 43 |
| Preferences | 3 | 15 | 25 | 43 |
| Perception of clinical research | 4 | 16 | 24 | 44 |
| Method | 5 | 14 | 27 | 46 |
| Informed consent | 5 | 16 | 26 | 47 |
| Benefits | 5 | 16 | 27 | 48 |
| The work environment | 3 | 18 | 27 | 48 |
| Terminology | 5 | 17 | 26 | 49 |
| Approach | 5 | 18 | 27 | 50 |
| Opinions about research | 6 | 18 | 27 | 51 |